Currently unavailable.
Tumor immunotherapy gets significant breakthroughs, particularly with the approval of immune checkpoint inhibitors (ICIs) and T-cell therapy. Scientists showed that some solid tumors targeting programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) molecules have a long-lasting clinical response and prolonged survival. Creative Biolabs provides specialized services in T cell cytotoxicity assay to successfully meet the requirements of your trial in the most effective and cost-efficient manner possible. in vitro t cell killing assay https://immune-checkpoint.crea....tive-biolabs.com/t-c